vrx# Stock
y*r
1 楼
May 31 (Reuters) - Valeant Pharmaceuticals Inc , which has come under
scrutiny for its business and accounting practices, said on Tuesday it would
host a conference call on June 7 to discuss first-quarter results.
The Beleaguered Canadian drugmaker reiterated that it expects to file its
quarterly report with U.S. and Canadian regulators on or before June 10,
ahead of a July 31 deadline.
scrutiny for its business and accounting practices, said on Tuesday it would
host a conference call on June 7 to discuss first-quarter results.
The Beleaguered Canadian drugmaker reiterated that it expects to file its
quarterly report with U.S. and Canadian regulators on or before June 10,
ahead of a July 31 deadline.